Marshall Wace
TVTX icon

Marshall Wace’s Travere Therapeutics TVTX Stock Holding History

Marshall Wace’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.3M Sell
178,536
-38,635
-18% -$1.15M 0.01% 1275
2025
Q4 		$8.3M Sell
217,171
-372,880
-63% -$12.1M 0.01% 940
2025
Q3 		$14.1M Sell
590,051
-152,674
-21% -$2.87M 0.01% 798
2025
Q2 		$11M Buy
+742,725
New +$12.3M 0.01% 806
2024
Q4 		– Sell
-111,341
Closed -$1.56M – 3016
2024
Q3 		$1.56M Buy
+111,341
New +$1.16M ﹤0.01% 1463
2023
Q4 		– Sell
-73,332
Closed -$656K – 2622
2023
Q3 		$656K Buy
+73,332
New +$1.03M ﹤0.01% 1635
2023
Q2 		– Sell
-214,498
Closed -$4.82M – 2976
2023
Q1 		$4.82M Buy
+214,498
New +$4.56M 0.01% 1015
2022
Q1 		– Sell
-6,866
Closed -$213K – 4033
2021
Q4 		$213K Sell
6,866
-45,441
-87% -$1.28M ﹤0.01% 3141
2021
Q3 		$1.27M Buy
+52,307
New +$961K 0.01% 1861
2021
Q2 		– Sell
-174,193
Closed -$4.35M – 3105
2021
Q1 		$4.35M Buy
+174,193
New +$4.81M 0.02% 915
2020
Q3 		– Sell
-98,976
Closed -$2.02M – 1930
2020
Q2 		$2.02M Buy
+98,976
New +$1.58M 0.01% 791
2016
Q3 		– Sell
-90,194
Closed -$1.61M – 1141
2016
Q2 		$1.61M Buy
90,194
+71,952
+394% +$1.16M 0.01% 632
2016
Q1 		$249K Buy
+18,242
New +$277K ﹤0.01% 950

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace's TVTX Position: Q1 2026 in Review

Marshall Wace reduced its Travere Therapeutics (TVTX) stake by 18% in Q1 2026, selling an estimated $1.15M and leaving 178,536 shares worth $5.3M. The position accounts for 0.01% of the portfolio, ranked #1275.

Marshall Wace first reported a position in TVTX in Q1 2016 and has held it in 13 quarters since. The position peaked at $14.1M in Q3 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Marshall Wace held 178,536 shares of Travere Therapeutics worth $5.3M as of Q1 2026.
  • Marshall Wace sold 38,635 Travere Therapeutics shares in Q1 2026, an estimated $1.15M.
  • Travere Therapeutics made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1275 holding.
  • Marshall Wace first reported a position in Travere Therapeutics in Q1 2016 and has held it in 13 quarters since.
  • Marshall Wace's Travere Therapeutics position peaked at $14.1M in Q3 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.